Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

107.8K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.8K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

4.1K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.1K
Improving Translational Accuracy02:07

Improving Translational Accuracy

3.7K
3.7K
Improving Translational Accuracy02:07

Improving Translational Accuracy

15.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.1K
Self-Discrepancy Theory02:45

Self-Discrepancy Theory

19.0K
One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.  
19.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Severe acute respiratory syndrome].

Medecine et maladies infectieuses·2024
Same author

Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.

Infectious diseases now·2022
Same author

[Viral pneumonia in immunocompetent patients].

Reanimation : journal de la Societe de reanimation de langue francaise·2020
Same author

[Ebola and others, those viruses coming from far away].

Reanimation : journal de la Societe de reanimation de langue francaise·2020
Same author

'A five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae' - Author's reply.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Isavuconazole brain penetration in cerebral aspergillosis.

The Journal of antimicrobial chemotherapy·2019
Same journal

[Etiology and clinical expression of angina].

Medecine et maladies infectieuses·2024
Same journal

[Rational use of antibiotics treatment in acute bronchitis].

Medecine et maladies infectieuses·2024
Same journal

Medecine et maladies infectieuses·2024
Same journal

[Detection of human rotaviruses in faeces : comparison of five methods].

Medecine et maladies infectieuses·2024
Same journal

Medecine et maladies infectieuses·2024
Same journal

Medecine et maladies infectieuses·2024
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1.8K

Exploring ways to improve CDI outcomes.

T Galpérine1, B Guery1, 1

  • 1Infectious diseases service, department of medicine, university Hospital, university of Lausanne, 46, rue du Bugnon, 1011 Lausanne, Switzerland.

Medecine Et Maladies Infectieuses
|January 17, 2018
PubMed
Summary
This summary is machine-generated.

New treatments for Clostridium difficile infection (CDI) are emerging, offering better outcomes than older drugs. Research highlights the role of gut microbiota and explores novel therapies like fidaxomicin and microbiota transplantation for CDI.

Keywords:
AntibioticsAntibiotiquesClostridium difficileFecal microbiota transplantationTransplantation fécaleVaccinVaccine

More Related Videos

Rodent Stereotaxic Surgery and Animal Welfare Outcome Improvements for Behavioral Neuroscience
07:01

Rodent Stereotaxic Surgery and Animal Welfare Outcome Improvements for Behavioral Neuroscience

Published on: January 30, 2012

40.0K
A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
07:37

A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes

Published on: October 28, 2021

3.5K

Related Experiment Videos

Last Updated: Feb 15, 2026

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1.8K
Rodent Stereotaxic Surgery and Animal Welfare Outcome Improvements for Behavioral Neuroscience
07:01

Rodent Stereotaxic Surgery and Animal Welfare Outcome Improvements for Behavioral Neuroscience

Published on: January 30, 2012

40.0K
A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
07:37

A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes

Published on: October 28, 2021

3.5K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Clostridium difficile infection (CDI) is a significant global health concern caused by an anaerobic, spore-forming bacterium.
  • Metronidazole and vancomycin were historically the primary treatments for CDI.
  • Recent advancements have improved the management of both initial and recurrent CDI episodes.

Purpose of the Study:

  • To review the evolving landscape of Clostridium difficile infection (CDI) management.
  • To highlight new therapeutic strategies and their impact on CDI treatment outcomes.
  • To discuss the role of gut microbiota in CDI recurrence and novel treatment approaches.

Main Methods:

  • Review of current literature on CDI pathophysiology and treatment.
  • Analysis of clinical trial data for new anti-CDI drugs.
  • Evaluation of emerging therapies including microbiota transplantation, passive immunotherapy, and vaccines.

Main Results:

  • Fidaxomicin demonstrated a significant reduction in CDI recurrences compared to vancomycin.
  • Several new drugs (cadazolid, surotomycin, ridinilazole, rifaximin) are under evaluation.
  • Gut microbiota homeostasis is crucial for preventing CDI recurrence, leading to developments in transplantation and substitution therapies.

Conclusions:

  • CDI treatment has advanced significantly with the development of novel therapeutic pathways.
  • Emerging treatments offer improved efficacy and reduced recurrence rates.
  • New therapeutic strategies for CDI require integration into international clinical guidelines.